Skip to main content

Table 2 Lung function testing of infants treated with and without PDA ligation

From: Lung function in very low birth weight infants after pharmacological and surgical treatment of patent ductus arteriosus - a retrospective analysis

 

N

hsPDA successfully treated with COX inhibitors

PDA ligation after unsuccessful treatment with COX inhibitors

p-value

Tidal breathing

 VT (mL/kg)

107

5.96 (5.27 – 6.39)

5.15 (4.35 – 6.10)

0.007

 RR (1/min)

107

40.0 (36.0 – 47.0)

43.5 (36.0 – 47.0)

0.132

 V’E (mL/min/kg)

107

234.2 (207.3 – 274.3)

221.6 (186.6 – 252.0)

0.137

 PTIF (L/min/kg)

107

0.85 (0.77 – 1.0)

0.87 (0.71 – 0.98)

0.984

 PTEF (L/min/kg)

107

0.77 (0.64 – 0.96)

0.71 (0.58 – 0.88)

0.078

 tptef/te (%)

107

18.1 (14.1 – 24.5)

17.2 (15.4 – 23.3)

0.896

Forced expiratory flow

 V’max FRC (mL/s)

95

42.0 (25.0 – 61.0)

31.0 (13.0 – 52.0)

0.019

 Z-Score V’maxFRC

95

−1.82 (−2.48 – −1.07)

−2.53 (−3.0 – −1.74)

0.006

Respiratory Mechanics

 Crs (mL/kPa/kg)

114

9.6 (8.1 – 10.6)

7.2 (6.3 – 9.1)

<0.001

 Rrs (kPa/L/s)

114

6.6 (5.2 – 8.3)

7.5 (6.3 – 8.3)

0.076

 Raw (kPa/L/s)

114

2.84 (1.70 – 4.19)

4.81 (3.64 – 6.14)

<0.001

Lung volumes and lung clearing index

 FRCPleth (mL/kg)

114

20.9 (18.8 – 24.2)

21.1 (18.0 – 23.9)

0.852

 FRCSF6 (mL/kg)

76

19.7 (15.6 – 24.3)

22.4 (18.6 – 25.2)

0.168

 LCI

76

6.0 (5.5 – 6.8)

6.0 (5.7 – 6.9)

0.601

Exhalation gas analysis

 eNO (ppb)

45

9.0 (3.3 – 18.2)

7.9 (3.7 – 11.3)

0.851

 V’NO (nL/s)

45

11.8 (3.8 – 26.4)

14.4 (7.3 – 26.4)

0.617

Blood gas analysis

 paO2 (mmHg)

113

70.6 (60.7 – 80.7)

59.7 (50.8 – 70.9)

<0.001

 paCO2 (mmHg)

113

40.9 (38.1 – 44.3)

45.1 (42.0 – 52.2)

<0.001

  1. N: number of lung function tests, presented as median and (IQR), statistically significant p-values are printed in bold